cystic renal dysplasia
Recently Published Documents


TOTAL DOCUMENTS

19
(FIVE YEARS 1)

H-INDEX

5
(FIVE YEARS 0)

Urology ◽  
2021 ◽  
Author(s):  
Danly Omil-Lima ◽  
Karishma Gupta ◽  
Megan Prunty ◽  
Eiichi A. Miyasaka ◽  
Emily L. Joyce ◽  
...  


2019 ◽  
Vol 23 (3) ◽  
pp. 235-239
Author(s):  
Sakil Kulkarni ◽  
Brooj Abro ◽  
Maria Laura Duque Lasio ◽  
Janis Stoll ◽  
Dorothy K Grange ◽  
...  

We report a term female infant born to nonconsanguineous parents who presented with renal failure at birth, hypothyroidism, cholestasis, and progressive cardiac dysfunction. Multigene next-generation sequencing panels for cholestasis, cardiomyopathy, and cystic renal disease did not reveal a unifying diagnosis. Whole exome sequencing revealed compound heterozygous pathogenic variants in ANKS6 (Ankyrin Repeat and Sterile Alpha Motif Domain Containing 6), which encodes a protein that interacts with other proteins of the Inv compartment of cilium ( NEK8, NPHP2/INVS, and NPHP3). ANKS6 has been shown to be important for early renal development and cardiac looping in animal models. Autopsy revealed cystic renal dysplasia and cardiomyocyte hypertrophy, disarray, and focal necrosis. Liver histology revealed cholestasis and centrilobular necrosis, which was likely a result of progressive cardiac failure. This is the first report of compound heterozygous variants in ANKS6 leading to a nephronopthisis-related ciliopathy-like phenotype. We conclude that pathogenic variants in ANKS6 may present early in life with severe renal and cardiac failure, similar to subjects with variants in genes encoding other proteins in the Inv compartment of the cilium.



Author(s):  
T. P. Makarova ◽  
V. P. Bulatov ◽  
N. V. Samoylova ◽  
G. M. Samoylova ◽  
L. V. Poladova ◽  
...  

Cystic dysplasia is a heterogeneous group of diseases, with 12–15% share in the structure of congenital kidney anomalies and 8–10% share in the structure of the causes of chronic renal failure in children. The article presents the results of observation of patients with polycystic kidney disease. To study the clinical features of the course of various forms of cystic dysplasia in children we analyzed the histories of children with autosomal recessive and autosomal dominant polycystic kidney disease. We revealed clinical, laboratory and instrumental features of the course of various types of cystic renal dysplasia.



PLoS ONE ◽  
2018 ◽  
Vol 13 (9) ◽  
pp. e0204073 ◽  
Author(s):  
Kati J. Dillard ◽  
Marjo K. Hytönen ◽  
Daniel Fischer ◽  
Kimmo Tanhuanpää ◽  
Mari S. Lehti ◽  
...  


2016 ◽  
Vol 57 (5) ◽  
pp. 440-443 ◽  
Author(s):  
Vineet Tyagi ◽  
Eran Bornstein ◽  
Robert Schacht ◽  
Shailee Lala ◽  
Sarah Milla


2012 ◽  
Vol 28 (1) ◽  
pp. 227-232 ◽  
Author(s):  
R. Schild ◽  
T. Knuppel ◽  
M. Konrad ◽  
C. Bergmann ◽  
A. Trautmann ◽  
...  


2012 ◽  
Vol 15 (1) ◽  
pp. 50-57 ◽  
Author(s):  
Katharina Schoner ◽  
Barbara Fritz ◽  
Georg Huelskamp ◽  
Frank Louwen ◽  
Martin Zenker ◽  
...  

We report on a triplet pregnancy of consanguineous parents with one fetus being affected by recurrent Johanson-Blizzard syndrome (JBS). At autopsy in the 35th gestational week, the affected triplet presented with an especially severe and lethal manifestation of the disorder as compared to his elder affected brother and to cases in the literature, thus exemplifying great interfamilial and intrafamilial phenotypic variability. Arhinencephaly and cystic renal dysplasia associated with urethral obstruction sequence were features not described previously in the literature. In addition to the lack of exocrine acini as the characteristic feature of JBS, the pancreas revealed a resorptive inflammatory reaction with infiltration by eosinophilic granulocytes that focally dispersed onto islets of Langerhans, thus favoring a progressive destructive rather than primary dysplastic process and possibly explaining the occurrence of diabetes mellitus in later life. JBS maps to chromosome 15q15-q21.1 and is associated with mutations in the UBR1 gene. Testing the fetus and the affected sibling revealed a homozygous truncating mutation in UBR1. The resulting absence of the UBR1 protein was confirmed by Western blot. Immunohistochemical staining using a commercial anti-UBR1 antibody demonstrated staining, presumably artifactual. This finding suggests that, until an appropriately validated antibody has been identified, this modality should not be utilized for diagnosis or confirmation of this disorder.



2011 ◽  
Vol 33 (1) ◽  
pp. 86-90 ◽  
Author(s):  
Marine R.-C. Kraus ◽  
Séverine Clauin ◽  
Yvan Pfister ◽  
Massimo Di Maïo ◽  
Tim Ulinski ◽  
...  


2011 ◽  
Vol 172 (7) ◽  
pp. 877-881 ◽  
Author(s):  
Ana-Maria Calinescu-Tuleasca ◽  
Armand Bottani ◽  
Anne-Laure Rougemont ◽  
Jacques Birraux ◽  
Marie-Claire Gubler ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document